Patents Examined by Joseph Kosack
  • Metathesis catalysts containing onium groups
    Patent number: 9403860
    Abstract: Disclosed herein is a general method for the preparation of complexes containing a quaternary onium group in an inert ligand. Some of these complexes may be represented by formula 1: Methods for the preparation of complexes of formula 1, the preparation of intermediates and the use of complexes of formula 1 in metathesis reactions and a method for conducting an olefin metathesis reaction are also described.
    Type: Grant
    Filed: February 27, 2013
    Date of Patent: August 2, 2016
    Assignee: Apeiron Synthesis S.A.
    Inventors: Krzysztof Skowerski, Lukasz Gulajski, Michal Bieniek, Stefan Czarnocki, Grzegorz Szczpaniak, Celina Wierzbicka
  • Iridium-based complexes for ECL
    Patent number: 9399654
    Abstract: The present invention relates to novel iridium-based Ir(III) luminescent complexes, conjugates comprising these complexes as a label and their application, e.g. in the electrochemiluminescence based detection of an analyte.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: July 26, 2016
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Frank Bergmann, Robert Cysewski, Luisa de Cola, Sebastian Dziadek, Jesus Miguel Fernandez Hernandez, Hans-Peter Josel, Christoph Seidel
  • Method for producing salts having monofluoro-tricyanoborate anions
    Patent number: 9399650
    Abstract: The invention relates to a method for producing alkali metal salts having monofluoro-tricyanoborate anions from alkali metal tetrafluoroborates.
    Type: Grant
    Filed: June 6, 2014
    Date of Patent: July 26, 2016
    Assignee: Merck Patent GmbH
    Inventors: Nikolai (Mykola) Ignatyev, Jan Arke Peter Spenger, Johannes Landmann, Maik Finze
  • Boron subphthalocyanine compounds and method of making
    Patent number: 9394319
    Abstract: A compound comprising a boron subphthalocyanine moiety, a plurality of solubilizing substituents positioned on peripheral cyclic groups of the boron subphthalocyanine moiety and an axial substituent positioned on the boron atom of the boron subphthalocyanine moiety. The plurality of solubilizing substituents comprise an oxygen or sulfur containing functional group and a substituted or unsubstituted, linear, branched or cyclic, aliphatic or aromatic terminal hydrocarbyl group that is 8 or more carbon atoms in length, the hydrocarbyl group optionally containing one or more heteroatoms. The axial substituent is selected from the group consisting of halogen, alkyloxy, haloalkyloxy, ester, carbonyl substituted alkyl, carbonyl substituted haloalkyl, alkylaryloxy, haloalkylaryloxy, alkyl sulfonyl, haloalkyl sulfonyl, alkylaryl sulfonyl and haloalkylaryl sulfonyl.
    Type: Grant
    Filed: August 28, 2013
    Date of Patent: July 19, 2016
    Assignee: XEROX CORPORATION
    Inventors: Jeffrey H. Banning, Wolfgang G. Wedler, Stephan V. Drappel
  • Method of separating carbon nanotubes
    Patent number: 9394262
    Abstract: Provided is a method of separating carbon nanotubes, the method comprising: forming first carbon nanotubes having a first functional group, forming a substrate having a second functional group, and causing the first carbon nanotubes to adhere to the substrate by a click chemistry reaction between the first functional group and the second functional group.
    Type: Grant
    Filed: August 22, 2013
    Date of Patent: July 19, 2016
    Assignees: SAMSUNG ELECTRONICS CO., LTD., GACHON UNIVERSITY OF INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Tae-Yong Kwon, Woo-Jae Kim, Hyung-Sam Kim
  • Chromophores with perfluoroalkyl substituents
    Patent number: 9388206
    Abstract: The present invention relates to specific metal complexes of dithiolenes with perfluoroalkyl substituted imidazolidine-2-chalcogenone-4,5-dithione ligands, a process for their preparation and their use as colourless IR absorbers, for optical filters application; especially for plasma display panels, or for laser welding of plastics. The compounds may be used in compositions for inks, paints and plastics, especially in a wide variety of printing systems and are particularly well-suited for security applications.
    Type: Grant
    Filed: April 25, 2012
    Date of Patent: July 12, 2016
    Assignee: BASF SE
    Inventors: Urs Lehmann, Daniel Heizler
  • Phosphine ligands for catalytic reactions
    Patent number: 9381508
    Abstract: The disclosure is directed to: (a) phosphacycle ligands; (b) catalyst compositions comprising phosphacycle ligands; and (c) methods of using such phosphacycle ligands and catalyst compositions in bond forming reactions.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: July 5, 2016
    Assignee: ABBVIE INC.
    Inventors: Shashank Shekhar, Thaddeus S. Franczyk, David M. Barnes, Travis B. Dunn, Anthony R. Haight, Vincent S. Chan
  • Organic dyes having rigid donor, process for producing the same, and dye-sensitized solar cell
    Patent number: 9376567
    Abstract: The present invention provides organic dyes having a rigid donor and the process for producing the same. The organic dye has the structure of formula (i) or formula (ii), wherein r1 is selected from h or c1-c18 alkyl; r5 is selected from h, c1-c18 alkyl or c1-c18 alkoxy; r6 and r7 are independently selected from h, c1-c18 alkyl, c1-c18 alkoxyphenyl or c1-c18 alkylphenyl; x is selected from any one of the groups represented by formulae (a) to (d); y is selected from a group represented by formula (e) or formula (f); in the formula (e), r2 and r3 are independently selected from h, f, c1-c18 alkyl or c1-c18 alkoxyphenyl; r4 is selected from any one of the groups represented by formulae (g) to (i). The present invention also provides a dye-sensitized solar cell which has a dye layer made from said organic dyes and has a relatively high power conversion efficiency.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: June 28, 2016
    Assignee: Changchun Institute of Applied Chemistry Chinese Academy of Sciences
    Inventors: Peng Wang, Zhaoyang Yao
  • Preparation method of zeolitic imidazolate framework-90 in water-based system
    Patent number: 9376453
    Abstract: The present invention provides a preparation method of Zeolitic Imidazolate Framework-90 (ZIF-90) in water-based system, which uses pure water as a solvent, and the reaction is carried out at room temperature. In addition, the present invention provides a preparation method of ZIF-90, and the particle size and the uniformity of the obtained ZIF-90 are controllable by addition of adjuvant or additive (Polyvinylpyrrolidone).
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: June 28, 2016
    Assignee: NATIONAL CENTRAL UNIVERSITY
    Inventors: Fa-Kuen Shieh, Shao-Chun Wang
  • Compositions and methods related to inhibitors of JAK kinase
    Patent number: 9371265
    Abstract: Embodiments are directed to JAK kinase inhibiting prodrug compounds of Formula Ib, containing a promoiety that results in alcohol derivative of the parent compound upon removal and methods of using an effective amount of said prodrug compounds in the treatment of a JAK-mediated disease or disorder in a subject. Preferred promoieties include phosphate, phosphonate, phosphate salt, sulfate, or sulfate salt.
    Type: Grant
    Filed: March 26, 2013
    Date of Patent: June 21, 2016
    Inventors: Federica Pericle, Jeremy A. Ross
  • Metathesis catalysts containing onium groups
    Patent number: 9371345
    Abstract: Disclosed herein is a general method for the preparation of complexes containing a quaternary onium group in an inert ligand. Some of these complexes may be represented by formula 1: Methods for the preparation of complexes of formula 1, the preparation of intermediates and the use of complexes of formula 1 in metathesis reactions and a method for conducting an olefin metathesis reaction are also described.
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: June 21, 2016
    Assignee: Apeiron Synthesis S.A.
    Inventors: Krzysztof Skowerski, Lukasz Gulajski, Michal Bieniek, Stefan Czarnocki, Grzegorz Szczpaniak, Celina Wierzbicka
  • Mitochondria-targeted inhibitors of cytochrome c peroxidase for protection from apoptosis
    Patent number: 9365597
    Abstract: The present application is directed to novel imidazole-substituted fatty acids that have been functionalized with an alkyl triphenylphosphonium group, compositions comprising these compounds and their use as inhibitors of cytochrome c peroxidase, in particular for the treatment and prevention of apoptosis.
    Type: Grant
    Filed: November 13, 2012
    Date of Patent: June 14, 2016
    Assignees: University of Pittsburgh—Of the Commonwealth System of Higher Education, Brock University
    Inventors: Jeffrey Atkinson, Jeffrey Stuart, Valarian E. Kagan, Detcho A. Stoyanovsky, Michael W. Epperly, Joel S. Greenberger, Hülya Bayîr
  • Method and apparatus for the intermixing of two fluid streams
    Patent number: 9364802
    Abstract: The subject of the present invention is an apparatus for the intermixing of a fluid stream with a fluid stream, which comprises a pipe through which the fluid stream is routed, at least two distributors for delivering the fluid stream being arranged inside the pipe, this arrangement of the distributors being made possible by bores in the casing of the pipe, and these distributors having a free flow cross section which is constant or decreases continuously, as seen in the main direction of flow of the fluid, and the distributors having one or more rows of holes for delivering the fluid into the fluid.
    Type: Grant
    Filed: February 28, 2012
    Date of Patent: June 14, 2016
    Assignee: BASF SE
    Inventors: Kerstin Heinen, Stefan Karbach, Burkhardt Dames, Wolfgang Haip, Wolfgang Gerlinger, Torsten Mattke
  • Boron-based 4-hydroxytamoxifen and endoxifen prodrugs as treatment for breast cancer
    Patent number: 9353132
    Abstract: The present disclosure relates to boron-based 4-hydroxytamoxifen and endoxifen prodrugs and the synthesis of the same. Further, the present disclosure teaches the utilization of the boron-based 4-hydroxytamoxifen and endoxifen prodrugs in a treatment for breast cancer.
    Type: Grant
    Filed: March 5, 2013
    Date of Patent: May 31, 2016
    Assignee: XAVIER UNIVERSITY OF LOUISIANA
    Inventors: Guangdi Wang, Shilong Zheng, Quan Jiang, Qiu Zhong, Qiang Zhang
  • Compositions and methods for improving glucose uptake
    Patent number: 9346835
    Abstract: A compound includes the structure of general Formula (II), pharmaceutically acceptable salts thereof, and/or solvates thereof: wherein R1, R2, R3, are independently selected from the group consisting of null, hydroxy, alkoxy, and halo, or R1 and R2 taken together form a cyclic boronate ester and R3 is null; wherein when four bonds to boron are present, boron bears a formal negative charge and the structure further comprises a countercation that is potassium or sodium, X1, X2, X3, and X4 are independently selected from the group consisting of O, CH, and N, with the proviso that no more than two of combined O and N are selected, and Z is selected from the group consisting of hydrogen, alkyl, aryl, heteroaryl, and halogen, any of which may be optionally substituted. Such compounds can increase glucose uptake by cells and preferably do not substantially increase adipogenesis.
    Type: Grant
    Filed: October 16, 2013
    Date of Patent: May 24, 2016
    Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Nikhil V. Dhurandhar, Bhaskar C. Das
  • Phosphonate derivatives and methods of use thereof in the treatment of Alzheimer's disease
    Patent number: 9346839
    Abstract: Benzothiazole phosphonate analogs and methods of using the same to inhibit the activity of Amyloid Binding Alcohol Dehydrogenase and in the amelioration or treatment of Alzheimer's disease are provided.
    Type: Grant
    Filed: November 12, 2014
    Date of Patent: May 24, 2016
    Assignee: University of Kansas
    Inventors: ShiDu Yan, Koteswara Rao Valasani
  • Crystalline forms
    Patent number: 9340565
    Abstract: Preparation and characterization of novel forms of (1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl) phosphonic acid, suitable for pharmaceutical compositions in drug delivery systems for humans.
    Type: Grant
    Filed: November 23, 2011
    Date of Patent: May 17, 2016
    Assignee: THAR PHARMACEUTICALS, INC.
    Inventors: Mazen Hanna, Ning Shan, Miranda L. Cheney, David R. Weyna, Paul K. Isbester, Xufeng Sun
  • Method for producing acrylonitrile
    Patent number: 9334233
    Abstract: The invention relates to a method for producing acrylonitrile which includes a vapor phase catalytic ammoxidation process of performing vapor phase catalytic ammoxidation by bringing a source gas containing propylene, molecular oxygen, and ammonia into contact with a fluidized bed catalyst to obtain acrylonitrile. The method is characterized in that the fluidized bed catalyst is a catalyst containing molybdenum and bismuth and the vapor phase catalytic ammoxidation process is performed while maintaining an adsorbed amount of ammonia per specific surface area (m2/g) of the fluidized bed catalyst in the range of 0.05 to 0.6 ?mol/m2. According to the method for producing acrylonitrile of the invention, it is possible to stably maintain a high acrylonitrile yield over a long period of time.
    Type: Grant
    Filed: February 26, 2013
    Date of Patent: May 10, 2016
    Assignee: Mitsubishi Rayon Co., Ltd.
    Inventors: Hirokazu Watanabe, Motoo Yanagita, Takashi Karasuda, Kazufumi Nishida, Kenichi Miyaki
  • Process of forming an amide
    Patent number: 9334230
    Abstract: A process is provided for the synthesis of an amide. A primary or secondary amine and a primary alcohol, with the amine and the alcohol being either moieties of different reactants or moieties of the same molecule, are contacted in the presence of a Ruthenium (II) catalyst. The Ruthenium (II) catalyst is free of a phosphine ligand. The process is also carried out in the absence of a phosphine. Providing the Ruthenium (II) catalyst includes providing an N-heterocyclic carbene.
    Type: Grant
    Filed: September 20, 2010
    Date of Patent: May 10, 2016
    Assignee: NANYANG TECHNOLOGICAL UNIVERSITY
    Inventors: Soon Hyeok Hong, Subhash Chandra Ghosh, Yao Zhang, Senthilkumar Muthaiah, Cheng Chen, Xiangya Xu
  • Colorant compounds
    Patent number: 9309410
    Abstract: Disclosed is a compound of the formula wherein Ra and Rb each, independently of the other, are hydrogen, alkyl, aryl, arylalkyl, or alkylaryl, R1 and R2 each, independently of the other, are hydrogen, alkyl, aryl, arylalkyl, or alkylaryl, provided that at least one of R1 and R2 is other than hydrogen, and R3, R4, R5, R6, and R7 each, independently of the others, are alkyl, aryl, arylalkyl, alkylaryl, or a substituent other than hydrogen, alkyl, aryl, arylalkyl, or alkylaryl, wherein in each case alkyl, aryl, arylalkyl, or alkylaryl may or may not be substituted and may or may not have hetero atoms therein, and wherein two or more of R3, R4, R5, R6, and R7 can be joined together to form a ring.
    Type: Grant
    Filed: August 28, 2013
    Date of Patent: April 12, 2016
    Assignee: XEROX CORPORATION
    Inventors: Jeffery H. Banning, Bo Wu, Nathan G. Starr, Stephan V. Drappel